Brief: Eurasia To Grant Precision Medicine Patent To Diamyd Medical

Diamyd Medical AB

10/09/2025 08:03

Sept 10 (Reuters) - Diamyd Medical AB DMYDb.ST:

EURASIA TO GRANT PRECISION MEDICINE PATENT TO DIAMYD MEDICAL FOR INSULIN ANTIGEN TREATMENT IN TYPE 1 DIABETES

PATENT IS VALID UNTIL 2038.

Source text: ID:nWkrblrmwm

Further company coverage: [DMYDb.ST]

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))